The Hain Celestial Group (HAIN) is a natural and organic food and personal-care products company. Six attributed analyst price targets were reviewed. Barclays analyst Andrew Lazar lowered his target to $0.30 (Underweight) in October 2026; Jefferies' Kaumil Gajrawala set $0.81 (Hold) in July 2026; Mizuho and Stephens each set $1.00, while Stifel also moved to $1.00 in early 2026. Maxim Group holds the most optimistic view at $3.00 (Buy), reiterated in September 2026. The average of these six targets is about $1.19, rounded to a $1.20 central target, within a $0.30 to $3.00 range.
Several of these targets predate the sharp deterioration in late 2026, when shares collapsed toward penny-stock levels. The wide range reflects genuine disagreement: cautious analysts emphasize revenue declines, competitive pressure, and leverage, while the most bullish view assumes a restructuring-driven recovery that materially restores profitability and balance-sheet strength. No single target should be treated as more likely than another, and the $1.20 mean is a mathematical average, not an official published consensus.
The stock has been trading near $0.12 to $0.14, down roughly 90% over the past year, with a market capitalization of only about $11 million. At approximately $0.14, the move to $1.20 represents an upside of roughly 750%, which is a very large required move. The path would likely depend first on stabilizing the balance sheet rather than on operating fundamentals alone. Hain has reported declining revenue, with fiscal 2026 revenue of roughly $1.35 billion, and the company disclosed that its auditor expressed doubt about its ability to continue as a going concern. Any sustained move higher would likely require resolving a substantial debt maturity, restoring compliance with Nasdaq's $1.00 minimum bid price rule, and convincing the market that the remaining North American business can return to growth.
The clearest supports are balance-sheet related. The company reached an agreement to sell its International business to AURELIUS for roughly $323 million, with net proceeds intended to reduce debt, and outlined about $16 million in annualized cost savings tied to a smaller, North America-focused footprint. A successful refinancing or extension of maturing debt, combined with a reverse stock split to restore the share price above $1.00, could reduce immediate liquidity and delisting overhangs. Any stabilization in revenue or signs that the remaining snacking and wellness portfolio is regaining share would bolster the more optimistic targets.
The obstacles are substantial. Bloomberg reported that the company was weighing a possible Chapter 11 filing, and the auditor's going-concern warning signals material uncertainty. Debt maturing in December 2026 remains unresolved, and the shares trade far below Nasdaq's $1.00 minimum bid price, forcing the company to consider a reverse split that often precedes further selling pressure. Continued revenue contraction, competitive pressure in natural and organic food, and the loss of the divested International business all reduce the earnings base that any meaningful re-rating would require. In an equity-restructuring scenario, existing shareholders could face severe dilution or see their interests largely wiped out.
The stock is trading near its 52-week low of roughly $0.12, far below the 52-week high of about $1.48. The $1.00 Nasdaq bid-price threshold now functions as a critical resistance level and regulatory milestone, while the prior low near $0.12 is the key downside support. Because shares have fallen below $1.00 for an extended period, the dominant market-structure question is not trend direction but whether the listing can be preserved, which adds binary event risk on top of ordinary price volatility.
Analyst price targets generally reflect a roughly 12-month research horizon, though the wide $0.30 to $3.00 dispersion here signals very different assumptions about survival and recovery. Investors should monitor the resolution of the December 2026 debt maturity, any refinancing announcement, the company's plan for Nasdaq compliance (including a potential reverse stock split), and the closing of the International business sale. Quarterly results, updates on the going-concern warning, and any Chapter 11 or restructuring news are the most consequential near-term items.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile and heavily event-driven name like HAIN, traders can use these signals to discover opportunities, monitor positions, and spot shifting trends more efficiently than manual review allows, particularly when headlines and technical conditions are changing quickly.
Reaching $1.20 would require Hain Celestial to rise roughly 750% from recent levels, an extraordinary move for a company facing a going-concern warning, unresolved near-term debt maturities, and Nasdaq delisting pressure. The $1.20 figure is simply the average of six widely divergent analyst targets ($0.30 to $3.00), several of which were set before the stock's late-2026 collapse. The most bullish scenarios hinge on a successful deleveraging and restructuring, while the most cautious assume existing equity is substantially impaired. Investors should weigh the wide analyst disagreement and monitor refinancing, listing-compliance, and restructuring developments rather than treating any single target as a reliable price forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that HAIN and TR have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HAIN and TR's prices will move in lockstep.
| Ticker / NAME | Correlation To HAIN | 1D Price Change % | ||
|---|---|---|---|---|
| HAIN | 100% | -6.56% | ||
| TR - HAIN | 27% Poorly correlated | +0.46% | ||
| MDLZ - HAIN | 25% Poorly correlated | +0.64% | ||
| BRLS - HAIN | 23% Poorly correlated | +14.29% | ||
| WEST - HAIN | 22% Poorly correlated | -2.22% | ||
| BYND - HAIN | 22% Poorly correlated | +1.16% | ||
More | ||||
| Ticker / NAME | Correlation To HAIN | 1D Price Change % |
|---|---|---|
| HAIN | 100% | -6.56% |
| Food: Major Diversified industry (62 stocks) | 3% Poorly correlated | +3.82% |